LAMIFLO

Pharmaceutical preparations for the treatment of humans and animals, namely, pharmaceutical preparations for the treatment of myocardial ischemia, peripheral limb ischemia as may occur in diabetic neuropathy, muscle compartmentation syndrome, decubitus, hemorrhagic shock and acute and chronic kidney disease and veterinary pharmaceutical preparations for the treatment of myocardial ischemia, peripheral limb ischemia as may occur in diabetic neuropathy, muscle compartmentation syndrome, decubitus, hemorrhagic shock and acute and chronic kidney disease; Pharmaceutical preparations for treating brain ischemia; Pharmaceuticals for the treatment of cerebrovascular disease; Pharmaceutical agents affecting brain perfusion or blood flow